Cardinal Health, Inc. (NYSE:CAH) Holdings Cut by American Century Companies Inc.

American Century Companies Inc. cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 28.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,093,350 shares of the company’s stock after selling 424,616 shares during the quarter. American Century Companies Inc.’s holdings in Cardinal Health were worth $129,311,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Rothschild Investment LLC boosted its stake in Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after purchasing an additional 79 shares during the period. Private Trust Co. NA raised its holdings in shares of Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company’s stock valued at $110,000 after buying an additional 92 shares during the last quarter. Checchi Capital Advisers LLC boosted its position in shares of Cardinal Health by 2.7% during the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock worth $411,000 after buying an additional 93 shares during the period. MWA Asset Management grew its holdings in Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock worth $393,000 after buying an additional 95 shares in the last quarter. Finally, Transcend Capital Advisors LLC increased its position in Cardinal Health by 3.6% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock valued at $323,000 after acquiring an additional 96 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $131.80 on Monday. The company has a market capitalization of $31.84 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The stock has a fifty day moving average of $127.35 and a 200-day moving average of $120.08. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $133.67.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.53%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. JPMorgan Chase & Co. increased their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Wells Fargo & Company raised their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Finally, Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $139.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.